Alpha-synuclein as a biomarker of Parkinson’s disease

Parkinsons disease (PD) is a common neurodegenerative disorder.Toxic aggregation of a small presynaptic protein alpha-synucleinis considered to be the main step in the pathogenesis of PD.Today there are no suitable diagnostic tests based on biochemicalinvestigation of such readily accessible tissues...

Full description

Bibliographic Details
Main Author: S. N. Pchelina
Format: Article
Language:English
Published: Research Center of Neurology 2017-02-01
Series:Анналы клинической и экспериментальной неврологии
Subjects:
Online Access:https://annaly-nevrologii.com/journal/pathID/article/viewFile/289/195
_version_ 1818240600919506944
author S. N. Pchelina
author_facet S. N. Pchelina
author_sort S. N. Pchelina
collection DOAJ
description Parkinsons disease (PD) is a common neurodegenerative disorder.Toxic aggregation of a small presynaptic protein alpha-synucleinis considered to be the main step in the pathogenesis of PD.Today there are no suitable diagnostic tests based on biochemicalinvestigation of such readily accessible tissues as blood andcerebrospinal fluid (CSF). A search for PD biomarkers aimed atdiagnosis and monitoring of the disease remains very actual. Assuggested in several studies, the use of the peripheral alphasynucleinlevel might be a prognostic marker for PD, but untilnow this question remains open. Evaluation of blood and CSFalpha-synuclein levels in patients with PD compared with agematchedcontrols provided conflicting results. Specific detectionand quantification of oligomeric forms of alpha-synuclein incombination with the improvement of imaging techniques maybe considered as most perspective direction.
first_indexed 2024-12-12T13:16:02Z
format Article
id doaj.art-c93197ca003a4df4ac2152ab51b6bd72
institution Directory Open Access Journal
issn 2075-5473
2409-2533
language English
last_indexed 2024-12-12T13:16:02Z
publishDate 2017-02-01
publisher Research Center of Neurology
record_format Article
series Анналы клинической и экспериментальной неврологии
spelling doaj.art-c93197ca003a4df4ac2152ab51b6bd722022-12-22T00:23:24ZengResearch Center of NeurologyАнналы клинической и экспериментальной неврологии2075-54732409-25332017-02-0154465110.17816/psaic289196Alpha-synuclein as a biomarker of Parkinson’s diseaseS. N. Pchelina0St. Petersburg State Medical University named after I.P. Pavlov (St. Petersburg)Parkinsons disease (PD) is a common neurodegenerative disorder.Toxic aggregation of a small presynaptic protein alpha-synucleinis considered to be the main step in the pathogenesis of PD.Today there are no suitable diagnostic tests based on biochemicalinvestigation of such readily accessible tissues as blood andcerebrospinal fluid (CSF). A search for PD biomarkers aimed atdiagnosis and monitoring of the disease remains very actual. Assuggested in several studies, the use of the peripheral alphasynucleinlevel might be a prognostic marker for PD, but untilnow this question remains open. Evaluation of blood and CSFalpha-synuclein levels in patients with PD compared with agematchedcontrols provided conflicting results. Specific detectionand quantification of oligomeric forms of alpha-synuclein incombination with the improvement of imaging techniques maybe considered as most perspective direction.https://annaly-nevrologii.com/journal/pathID/article/viewFile/289/195parkinson’s diseasebiomarkersalpha-synuclein
spellingShingle S. N. Pchelina
Alpha-synuclein as a biomarker of Parkinson’s disease
Анналы клинической и экспериментальной неврологии
parkinson’s disease
biomarkers
alpha-synuclein
title Alpha-synuclein as a biomarker of Parkinson’s disease
title_full Alpha-synuclein as a biomarker of Parkinson’s disease
title_fullStr Alpha-synuclein as a biomarker of Parkinson’s disease
title_full_unstemmed Alpha-synuclein as a biomarker of Parkinson’s disease
title_short Alpha-synuclein as a biomarker of Parkinson’s disease
title_sort alpha synuclein as a biomarker of parkinson s disease
topic parkinson’s disease
biomarkers
alpha-synuclein
url https://annaly-nevrologii.com/journal/pathID/article/viewFile/289/195
work_keys_str_mv AT snpchelina alphasynucleinasabiomarkerofparkinsonsdisease